Challenges of Synthetic Organic Drug Development
Keywords:
Grambharti, Amrapur, Basic Education, Buniyadi Sikshan, Constructive learningAbstract
This research paper delves into the critical area of synthetic organic drug development, with a particular focus on impurity profiling. The pharmaceutical industry's commitment to producing high-quality and safe medications is emphasized, as well as the significance of analytical methods and their validation. Impurities, their sources, and the impact of impurity levels on drug safety are explored. The study presents a literature review of research work in the field, highlighting the development and validation of methods for drug quantification. The research topic and objectives are outlined, and the research methodology, including instrumentation, solvents, and data collection, is described in detail. Method validation parameters, the perspectives of the present research, and the scope and limitations are discussed. The importance of this research in maintaining drug quality and purity is underscored, especially in the context of impurity profiling.
Downloads
References
• Blacker, J., & Williams, M. T. (Eds.). (2011). Pharmaceutical process development: current chemical and engineering challenges. Royal Society of Chemistry.
• Bolton S (1997) Pharmaceutical Statistics: Practical and Clinical Applica-tion, 3rd edition, Marcel Dekker, New York: 216–269
• Bruice, P. Y. (2017). Organic chemistry. Pearson.
• Chandran, Sajeev and R. S. Prasad Singh (2007). Comparison of various international guidelines for analytical method validation. Pharmazie 62 (2007): 1-13
• D. Jain and P. K. Basniwal (2013). Journal of Pharmaceutical and Biomedical Analysis 86:11-35.
• Green J M (1996) A practical guide to analytical method validation. AnalChem 305A-309A
• Miller JC and Miller JN (1988) Basic statistics methods for analytical chemis-try part 1-Statistics of repeated measures Analyst 113: 1351–1356
• S. Sharma S. Goyal and K.A. Chauhan (2018), International Journal of Applied Pharmaceutics 10(6): 8-15.
• S. Niazi (2009). Handbook Impurities in New Drug Substances; Hand. Pharm Sarfaraz 2, 118–122.
• Willard HH, Meritt LL, Dean JA, Settle FA (1995) Instrumental Method ofAnalysis, CBS Publishers, New Delhi, 7th Edn., 2–17
• Wong, C. H. (1994). Enzymes in synthetic organic chemistry (Vol. 12). Elsevier.